Back to Gene
TAT gene
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Gene

TAT gene

The TAT gene provides instructions for producing the liver enzyme tyrosine aminotransferase, which is essential for breaking down the amino acid tyrosine.

Normal Function

The TAT gene provides instructions for making a liver enzyme called tyrosine aminotransferase. This enzyme is the first in a series of five enzymes that work to break down the amino acid tyrosine, a protein building block found in many foods. Specifically, tyrosine aminotransferase converts tyrosine into a byproduct called 4-hydroxyphenylpyruvate. This process continues until smaller molecules are produced that are either excreted by the kidneys or used to produce energy or make other substances in the body.

Health Conditions Related to Genetic Changes

Tyrosinemia

At least 22 TAT gene mutations have been found to cause tyrosinemia type II, a condition that often affects the eyes, skin, and mental development.

  • Mechanism: Most mutations change single DNA building blocks (base pairs) within the TAT gene, resulting in an enzyme with reduced activity. Other mutations delete all or part of the gene, eliminating enzyme activity entirely.
  • Impact: As a result, tyrosine is not properly broken down, leading to elevated tyrosine levels. Some tyrosine is converted into other molecules that may be toxic to cells.

It is currently unclear how the impaired breakdown of tyrosine leads to the specific skin, eye, and intellectual problems that characterize tyrosinemia type II.

Other Names for This Gene

  • ATTY_HUMAN
  • L-tyrosine:2-oxoglutarate aminotransferase
  • tyrosine transaminase

Frequently Asked Questions

Tyrosinemia type II is an autosomal recessive genetic condition. This means that an individual must inherit two copies of a mutated TAT gene (one from each parent) to develop the disorder. If both parents are carriers of a single mutated TAT gene, there is a 25% chance with each pregnancy that their child will inherit two mutated copies and develop tyrosinemia type II, a 50% chance the child will be a carrier, and a 25% chance the child will not inherit any mutated copies. Genetic counseling can provide detailed risk assessments and testing options for families.
The primary treatment for tyrosinemia type II involves a strict low-tyrosine and low-phenylalanine diet. This specialized diet helps reduce the accumulation of tyrosine and its toxic byproducts in the body. Regular monitoring of tyrosine levels in the blood is essential to adjust the diet as needed.
Tyrosinemia type II often presents with specific symptoms affecting the eyes, skin, and neurological development. Eye symptoms can include redness, pain, and sensitivity to light, sometimes with corneal ulcers. Skin lesions, particularly on the palms and soles, may appear as painful, thickened patches. Developmental delays and intellectual disability can also be observed as the condition progresses.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA